People · Operator
Named in public records as an officer, director or promoter · active 2016–2020 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sagimet Biosciences Inc. | — | Biotechnology | Series C | $166.6M | $2.4B | 2016 |
Jason Fuller at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jason Fuller on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Beth Seidenberg | 1 | 15 |
| David Mott | 1 | 9 |
| Gordon Ringold | 1 | 7 |
| Robert Garland | 1 | 7 |
| James Young | 1 | 4 |
| Richard Rodgers | 1 | 4 |
| Rick Klausner | 1 | 2 |
| John Curnutte | 1 | 2 |
| Ari Helenius | 1 | 1 |
| Merdad Parsey | 1 | 1 |
| Rekha Hemrajani | 1 | 1 |
| George Kemble | 1 | 1 |
| Dennis Hom | 1 | 1 |
| Jinzi Jason Wu | 1 | 1 |
| Xufang Jason Duan | 1 | 1 |
| Dennis Jason Hom | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.